Home / Brands / ASTRAZENECA PHARMACEUTICALS
ASTRAZENECA PHARMACEUTICALS Recalls
6 recalls on record · August 14, 2013 to October 22, 2025 · Drugs
Recalls by year
13
15
16
17
18
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
October 22, 2025DrugsFDA
ASTRAZENECA PHARMACEUTICALS recalls Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB
Hazard: Lack of Assurance of Sterility:
March 14, 2018DrugsFDA
AstraZeneca Pharmaceuticals LP recalls Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmin
Hazard: Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
July 19, 2017DrugsFDA
AstraZeneca Pharmaceuticals, LP recalls BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceutical
Hazard: Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.
March 30, 2016DrugsFDA
AstraZeneca Pharmaceuticals LP recalls Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only.
Hazard: Defective Delivery System: Some units have actuation counters set to a number other than 60.
June 24, 2015DrugsFDA
AstraZeneca Pharmaceuticals LP recalls NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZenec
Hazard: Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
August 14, 2013DrugsFDA
AstraZeneca Pharmaceuticals LP recalls MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceutica
Hazard: Presence of Precipitate; potential for incomplete constitution upon addition of diluent.